1. Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products

   • Jonathan Fialkow

   Current Opinion Open access 30 April 2016 Pages: 229 - 239

   

2. Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine

   • Michel E. Bertrand
   • Charalambos Vlachopoulos
   • Jean-Jacques Mourad

   Review Article 02 June 2016 Pages: 241 - 253

   

3. The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?

   • Csaba András Dézsi

   Review Article Open access 03 March 2016 Pages: 255 - 266

4. Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study

   • Arturo Cafolla
   • Alessandra Gentili
   • Roberta Curini

   Original Research Article 15 April 2016 Pages: 267 - 274

   

5. Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study

   • Remo Holanda de Mendonça Furtado
   • Robert Patrick Giugliano
   • José Carlos Nicolau

   Original Research Article 11 June 2016 Pages: 275 - 284

   

6. A State Transition Model for Health Outcomes Associated with Vorapaxar Treatment as an Add-on to Standard Care Antiplatelet Therapy in the Prevention of Thrombotic Events for Patients with a Recent Myocardial Infarction

   • John D. Whalen
   • Glenn Davies
   • Ipek Ozer-Stillman

   Original Research Article 04 June 2016 Pages: 285 - 295

   

7. Idarucizumab: A Review as a Reversal Agent for Dabigatran

   • Yahiya Y. Syed

   Adis Drug Evaluation 07 July 2016 Pages: 297 - 304

8. 65th Annual Scientific Sessions of the American College of Cardiology: 2–4 April 2016; Chicago, IL, USA

   • Amitabh Prakash

   Meeting Report 25 June 2016 Pages: 305 - 308